Fredun Pharmaceuticals has received orders worth Rs 28 crore from Southeast Asian (SEA) countries, the healthcare solutions company has said.
The orders not only demonstrate its growing presence in the international markets but also its potential to scale up, the company said.
The company was developing three new molecules, as part of its commitment to pioneering advancements in pet and veterinary care, the company told exchanges.
Follow our live blog for all market action
The stock, however, was trading 2 percent down at 12.30 pm on BSE, taking cues from the markets. The Sensex and the Nifty were down over a percent. Pharma stocks were outperforming, with the Nifty healthcare index up by 0.43 percent.
The Zydus Life shares were up by 7 percent after the company announced a good set of results and a buyback of shares worth Rs 600 crore. Dr Reddy’s rose to new highs after gaining up by to 2.45 percent.
Apart from the Nifty healthcare index, the Nifty IT index was up 1.14 percent.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
